gip receptor tirzepatide Bumps and humps in the success of as the first GLP1 and agonist Systemic effects of tirzepatide dually

Maintaining appropriate hydration is essential for patients taking GLP-1 medications, particularly given the common gastrointestinal side effects that can affect fluid balance

This formulation is available only through prescription for patients with a demonstrated clinical need

About In 2024, , and it is also part of the Nasdaq-100 Index , which includes the largest and most innovative non-financial companies listed on the For more information, visit Amgen.com and follow Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of No forward-looking statement can be guaranteed and actual results may differ materially from those we project

As of April 2026, the Wegovy oral tablet has not been approved for use in the United Kingdom

Pediatric safety and efficacy data remain limited